ALDX insider transaction filings
Aldeyra Therapeutics, Inc. — 39 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-11. Screen ALDX transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for ALDX between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Aldeyra Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-11 | 4 | Miller-Rich Nancy — Director | Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 3,318 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Clark William D — Director | Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 2,323 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Walker Neal — Director | Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 3,318 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Bronstein Ben — Director | Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 5,309 (derivative) @ $0 · Grant/award (A): 4,977 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Phillips Gary M. — Director | Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 6,636 (derivative) @ $0 · Grant/award (A): 4,977 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | DEPTULA-HICKS DARLENE M — Director | Grant/award (A): 84,557 (derivative) @ $0 · Grant/award (A): 9,756 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | DOUGLAS RICHARD — Director | Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 19,909 (derivative) @ $0 · Grant/award (A): 2,323 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Brady Todd C — President and CEO, Director | Purchase (P): 250,000 @ $1.67 | EDGAR |
| 2026-03-31 | 4 | Brady Todd C — President and CEO, Director | Grant/award (A): 1,880,510 (derivative) @ $0 · Grant/award (A): 632,318 (derivative) @ $0 | EDGAR |
| 2026-03-20 | 4 | DOUGLAS RICHARD — Director | Purchase (P): 70,000 @ $1.40 | EDGAR |
| 2026-03-19 | 4 | Alfieri Michael — Principal Financial Officer | Purchase (P): 5,000 @ $1.42 | EDGAR |
| 2025-08-15 | 4 | Alfieri Michael — Principal Financial Officer | Purchase (P): 2,500 @ $5.30 | EDGAR |
| 2025-08-13 | 4 | Machatha Stephen — Chief Development Officer | Sale (S): 22,073 @ $5.15 | EDGAR |
| 2025-06-12 | 4 | Walker Neal — Director | Grant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 2,413 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Miller-Rich Nancy — Director | Grant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 2,413 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Bronstein Ben — Director | Grant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 3,619 (derivative) @ $0 · Grant/award (A): 3,860 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | JOYCE MARTIN JOSEPH — Director | Grant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 1,689 (derivative) @ $0 · Grant/award (A): 7,238 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Phillips Gary M. — Director | Grant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 4,825 (derivative) @ $0 · Grant/award (A): 3,619 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | DOUGLAS RICHARD — Director | Grant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 14,476 (derivative) @ $0 · Grant/award (A): 1,689 (derivative) @ $0 | EDGAR |
| 2025-04-18 | 4 | Clark William D — Director | Grant/award (A): 76,760 (derivative) @ $0 | EDGAR |
| 2025-04-07 | 4 | PERCEPTIVE ADVISORS LLC — 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — 10% owner EDELMAN JOSEPH — 10% owner | Sale (S): 3,400,000 @ $1.42 | EDGAR |
| 2025-03-06 | 4 | Brady Todd C — President and CEO, Director | Grant/award (A): 809,710 (derivative) @ $0 | EDGAR |
| 2025-03-06 | 4 | Machatha Stephen — Chief Development Officer | Grant/award (A): 202,427 (derivative) @ $0 | EDGAR |
| 2024-10-21 | 4 | Miller-Rich Nancy — Director | Purchase (P): 413 @ $12.81 · Purchase (P): 509 @ $10.13 | EDGAR |
| 2024-08-14 | 4 | Machatha Stephen — Chief Development Officer | Sale (S): 16,041 @ $4.74 | EDGAR |
| 2024-08-14 | 4 | Greenberg Bruce — See Remarks | Sale (S): 10,834 @ $4.74 | EDGAR |
| 2024-06-06 | 4 | Walker Neal — Director | Grant/award (A): 40,282 (derivative) @ $0 · Grant/award (A): 1,736 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Miller-Rich Nancy — Director | Grant/award (A): 40,282 (derivative) @ $0 · Grant/award (A): 1,736 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Bronstein Ben — Director | Grant/award (A): 40,282 (derivative) @ $0 · Grant/award (A): 2,604 (derivative) @ $0 · Grant/award (A): 2,778 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | JOYCE MARTIN JOSEPH — Director | Grant/award (A): 40,282 (derivative) @ $0 · Grant/award (A): 1,215 (derivative) @ $0 · Grant/award (A): 5,209 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Phillips Gary M. — Director | Grant/award (A): 40,282 (derivative) @ $0 · Grant/award (A): 3,473 (derivative) @ $0 · Grant/award (A): 2,604 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | DOUGLAS RICHARD — Director | Grant/award (A): 40,282 (derivative) @ $0 · Grant/award (A): 10,418 (derivative) @ $0 · Grant/award (A): 1,215 (derivative) @ $0 | EDGAR |
| 2024-04-17 | 4/A | Machatha Stephen — Chief Development Officer | Sale (S): 11,537 @ $3.16 | EDGAR |
| 2024-04-17 | 4/A | Greenberg Bruce — See Remarks | Sale (S): 13,201 @ $3.41 | EDGAR |
| 2024-04-08 | 4 | PERCEPTIVE ADVISORS LLC — 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — 10% owner EDELMAN JOSEPH — 10% owner | Purchase (P): 140,281 @ $4.67 · Purchase (P): 37,712 @ $4.74 | EDGAR |
| 2024-04-03 | 4 | PERCEPTIVE ADVISORS LLC — 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — 10% owner EDELMAN JOSEPH — 10% owner | Purchase (P): 8,374 @ $3.25 · Purchase (P): 186,051 @ $3.44 · Purchase (P): 309,847 @ $4.09 | EDGAR |
| 2024-03-12 | 4 | Greenberg Bruce — See Remarks | Sale (S): 13,201 @ $3.41 · Grant/award (A): 252,280 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | Machatha Stephen — Chief Development Officer | Sale (S): 18,231 @ $3.41 · Sale (S): 11,537 @ $3.16 · Grant/award (A): 405,450 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | Brady Todd C — President and CEO, Director | Sale (S): 97,914 @ $3.27 · Sale (S): 85,324 @ $3.05 · Grant/award (A): 1,081,201 (derivative) @ $0 | EDGAR |
Recent 8-K events — Aldeyra Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-15 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-06-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-01 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-20 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-04-01 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-03-17 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-31 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-12-16 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-13 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ALDX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →